Skip to search formSkip to main contentSkip to account menu

vaninolol

Known as: (+-)4-(4'-(2-hydroxy-3-tert-butylaminopropoxy)-3'-methoxyphenyl)-3-buten-2-one 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ButanonesPropanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Ocular hypotensive and vasodilative effects of two beta-adrenergic blockers with intrinsic sympathomimetic activity.
PURPOSE The ocular hypotensive and vasodilative effects of vaninolol and eugenolol, two beta-adrenergic blockers with intrinsic… 
1995
1995
Vaninolol: a novel compound for the treatment of glaucoma and ischemic retinopathy.
Vaninolol has been confirmed as a selective beta 1-adrenergic blocking agent. The new compound was studied for its effects on… 
1994
1994
Vaninolol: a new selective beta 1-adrenoceptor antagonist derived from vanillin.
The beta-adrenoceptor blocking properties of vaninolol ((+/-)4-[4'-(2-hydroxy-3-tert-butyl-aminopropoxy)-3'-methoxyphenyl]- 3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)